An Ancient Evolutionary Advantage?

Shared sequences within the brain lipid-metabolism pathway between Neanderthals and modern Europeans highlight questions about how these genetic similarities arose.

Written byEmily Willingham
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

WIKIMEDIA, MATT CELESKY, DRMIKEBAXTERModern humans of European descent have a lot in common with their Neanderthal ancestors when it comes to genes related to fat breakdown in the brain. A team led by investigators from the Chinese Academy of Sciences in Shanghai has found that people of European descent have three times the number of Neanderthal-like sequences in such genes compared to other modern human populations examined. The results, published today (April 1) in Nature Communications, point to how studying ancestral sequences could help researchers better understand modern humans.

“This paper presents a sort of second-phase research using what we know about where genes have come from,” said John Hawks, a paleoanthropologist at the University of Wisconsin, Madison, who was not involved in the study. “For some that come from Neanderthals, we can use that information to learn something new about human genetics and human biology.”

To unravel whether genetics might influence how fat is broken down in the brain, the Russian Academy of Sciences’ Ekaterina Khrameeva and her colleagues compared gene sequence similarities among today’s Europeans, Asians, and Neanderthals relative to those from modern people of African descent. Previous studies have looked for patterns across genomes, but this group homed in on gene groups associated with metabolism, cancer, the immune system, and lipid ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies